333. DPH Biologicals’ Alex Cochran on a maturing ag biologics market + the importance of clearly stated ROI for growers
New data from AgFunder News shows that ag biologics are used by just under half of U.S. farmers. Dr. Alex Cochran, CTO of DPH Biologicals, joins today to share his unique perspective on this growing market. We discuss: What are ag biologicals and their r
Audio is streamed directly from the publisher (media.transistor.fm) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.
Show Notes
New data from AgFunder News shows that ag biologics are used by just under half of U.S. farmers. Dr. Alex Cochran, CTO of DPH Biologicals, joins today to share his unique perspective on this growing market.
We discuss:
- What are ag biologicals and their role in modern production agriculture.
- Biologicals as an important piece for growers as they manage a tough farm economy.
- The challenge of change when it comes to farming practices and the criticality of clearly describing ROI for growers.
- Movement in the biologicals market from big players like Corteva’s acquisition of Symborg and Stoller.
- DPH’s focus on differentiation and value to its growers + a deep dive into the conversations they’re having at the farmgate right now.
The biologicals market has come a long way, but is it still early innings? Alex talks how the technology has evolved what’s on the horizon for DPH Biologicals.